Impact of type 2 diabetes mellitus in hospitalizations for atrial fibrillation in Spain (2004

Impact of type 2 diabetes mellitus in hospitalizations for atrial fibrillation in Spain (2004–2013)

Published:2016-10 Issue: Volume:221 Page:688-694
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Méndez-Bailón Manuel,Muñoz-Rivas Nuria,Jiménez-García Rodrigo,Esteban-Hernández Jesús,Hernández-Barrera Valentín,de Miguel-Yanes José M,Lorenzo-Villalba Noel,Lopez-de-Andrés Ana

Funder

FIS

Grupo de Excelencia Investigadora URJC-Banco Santander

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century;Ball;Int. J. Cardiol.,2013

2. Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients;Wilke;Europace,2013

3. Global epidemiology of atrial fibrillation;Rahman;Nat. Rev. Cardiol.,2014

4. Trends in hospitalization for atrial fibrillation: epidemiology, cost, and implications for the future;Sheikh;Prog. Cardiovasc. Dis.,2015

5. Incidence of atrial fibrillation and relationship with cardiovascular events, heart failure, and mortality: a community-based study from the Netherlands;Vermond;J. Am. Coll. Cardiol.,2015

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glycemic control and atrial fibrillation: an intricate relationship, yet under investigation;Cardiovascular Diabetology;2022-03-14

2. Relationship between diabetes mellitus and atrial fibrillation prevalence in the Polish population: a report from the Non-invasive Monitoring for Early Detection of Atrial Fibrillation (NOMED-AF) prospective cross-sectional observational study;Cardiovascular Diabetology;2021-06-24

3. Prognostic significance of diabetes mellitus in patients with atrial fibrillation;Cardiovascular Diabetology;2021-02-11

4. Selección del tratamiento anticoagulante óptimo para el paciente con fibrilación auricular y diabetes o enfermedad renal crónica: papel del rivaroxabán;Revista Española de Cardiología Suplementos;2020

5. Type 2 Diabetes, Atrial Fibrillation, and Direct Oral Anticoagulation;Journal of Diabetes Research;2019-12-06